QUINLAN KEVIN W 4
4 · ANIKA THERAPEUTICS INC · Filed Mar 3, 2009
Insider Transaction Report
Form 4
QUINLAN KEVIN W
Chief Financial Officer
Transactions
- Award
Stock Appreciation Rights
2009-03-02$3.05/sh+30,000$91,500→ 30,000 totalExercise: $3.05Exp: 2019-03-02→ Common Stock (30,000 underlying)
Footnotes (1)
- [F1]The stock appreciation rights vest in four equal installments annually beginning March 2, 2010.